BRPI0517391A - forma de dosagem com lapso de tempo de medicamentos para a terapia de insÈnia - Google Patents

forma de dosagem com lapso de tempo de medicamentos para a terapia de insÈnia

Info

Publication number
BRPI0517391A
BRPI0517391A BRPI0517391-4A BRPI0517391A BRPI0517391A BR PI0517391 A BRPI0517391 A BR PI0517391A BR PI0517391 A BRPI0517391 A BR PI0517391A BR PI0517391 A BRPI0517391 A BR PI0517391A
Authority
BR
Brazil
Prior art keywords
dosage form
time
lapse
drugs
insomnia
Prior art date
Application number
BRPI0517391-4A
Other languages
English (en)
Inventor
Guy Vergnault
Pascal Grenier
Original Assignee
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec Ag filed Critical Jagotec Ag
Publication of BRPI0517391A publication Critical patent/BRPI0517391A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

FORMA DE DOSAGEM COM LAPSO DE TEMPO DE MEDICAMENTOS PARA A TERAPIA DE INSÈNIA. A presente invenção refere-se a métodos e composições para o tratamento de insónia e apresenta uma forma de dosagem contendo uma substância medicamentosa utilizável no tratamento de insónia, a forma de dosagem sendo adaptada para liberar a dita substância medicamentosa após um lapso de tempo, durante o qual substancialmente nenhuma substância medicamentosa é liberada, o lapso de tempo sendo de cerca de pelo menos uma hora após a administração da forma de dosagem.
BRPI0517391-4A 2004-10-28 2005-10-28 forma de dosagem com lapso de tempo de medicamentos para a terapia de insÈnia BRPI0517391A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0423964.6A GB0423964D0 (en) 2004-10-28 2004-10-28 Dosage form
PCT/EP2005/011568 WO2006045618A1 (en) 2004-10-28 2005-10-28 Dosage form time-lagged of drugs for the therapy of insomnia

Publications (1)

Publication Number Publication Date
BRPI0517391A true BRPI0517391A (pt) 2008-10-07

Family

ID=33515716

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0517391-4A BRPI0517391A (pt) 2004-10-28 2005-10-28 forma de dosagem com lapso de tempo de medicamentos para a terapia de insÈnia

Country Status (14)

Country Link
US (1) US20090297601A1 (pt)
EP (2) EP1814529B1 (pt)
JP (3) JP2008517970A (pt)
KR (2) KR20070090895A (pt)
CN (2) CN103394087A (pt)
AU (1) AU2005298854B2 (pt)
BR (1) BRPI0517391A (pt)
CA (1) CA2585910C (pt)
GB (1) GB0423964D0 (pt)
IL (1) IL182849A0 (pt)
MX (1) MX2007005065A (pt)
RU (1) RU2458685C2 (pt)
WO (1) WO2006045618A1 (pt)
ZA (1) ZA200703810B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007107878A2 (en) * 2006-03-17 2007-09-27 Aurobindo Pharma Limited Solid dosage forms of hypnotic agent
CA2746884A1 (en) * 2008-12-15 2010-07-01 Somnus Therapeutics, Inc. A method of treating insomnia
GB201003766D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Pulsatile drug release
GB201003734D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Delayed prolonged drug delivery
GB201003731D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Immediate/delayed drug delivery
CN102824327A (zh) * 2011-06-14 2012-12-19 天津药物研究院 含有阿戈美拉汀的肠溶片的药用组合物
CN102949376A (zh) * 2011-08-25 2013-03-06 天津药物研究院 一种含阿戈美拉汀的肠溶胶囊的药用组合物
CN102824331A (zh) * 2012-09-28 2012-12-19 河南中帅医药科技发展有限公司 扎来普隆双释放胶囊及其制备方法
PL2810656T3 (pl) * 2013-06-06 2018-01-31 Zentiva Ks Preparaty agomelatyny zawierające agomelatynę w postaci kokryształów
HUE047654T2 (hu) * 2014-02-06 2020-05-28 Lan Bo Chen Készítmény és módszer alvás segítésére
BR112016021206B1 (pt) * 2014-04-25 2022-07-12 Chugai Seiyaku Kabushiki Kaisha Composição farmacêutica, contendo composto tetracíclico em dose elevada e seu método de produção
CN104306349B (zh) * 2014-09-11 2017-08-25 常州欧法玛制药技术有限公司 一种含褪黑素的渗透泵控释片及其配制方法
CN104434848A (zh) * 2014-11-27 2015-03-25 河南中帅医药科技股份有限公司 一种择时释放的口服固体制剂及其制备方法
CN105640905B (zh) * 2014-12-02 2018-06-22 上海美迪西生物医药股份有限公司 氟硝西泮舌下片制剂及其制备方法
RU2694837C2 (ru) * 2017-07-06 2019-07-17 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Фармацевтическая композиция пролонгированного действия на основе 5-этокси-2-[2-(морфолино)-этилтио] бензимидазола дигидрохлорида и/или основания (Афобазола)
CN113274365B (zh) * 2021-07-22 2021-10-22 广东科泰鼎润药业科技有限公司 雷美替胺速释缓释双释放制剂及其制备方法
CN113274364B (zh) * 2021-07-22 2021-12-07 海南慧谷药业有限公司 雷美替胺缓释制剂及其制备方法
CN115707455B (zh) * 2021-08-18 2025-03-14 越洋医药开发(广州)有限公司 允许睡眠调节类药物分段释放的片剂及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
US4451260A (en) * 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
JPS63215620A (ja) * 1987-03-03 1988-09-08 Nippon Soda Co Ltd 徐放性製剤
JP3078859B2 (ja) * 1990-02-23 2000-08-21 武田薬品工業株式会社 安定な放出制御性製剤用コーティング剤
ES2083074T3 (es) * 1991-11-13 1996-04-01 Glaxo Canada Dispositivo de liberacion controlada.
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
HRP970493A2 (en) * 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
US6562375B1 (en) * 1999-08-04 2003-05-13 Yamanouchi Pharmaceuticals, Co., Ltd. Stable pharmaceutical composition for oral use
US6485746B1 (en) * 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
AU7335500A (en) * 1999-08-26 2001-03-19 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
GB0025208D0 (en) * 2000-10-13 2000-11-29 Euro Celtique Sa Delayed release pharmaceutical formulations
WO2002069974A1 (en) * 2001-03-05 2002-09-12 Andrew Holman Administration of sleep restorative agents
IL157633A0 (en) * 2001-03-13 2004-03-28 Penwest Pharmaceuticals Co Chronotherapeutic dosage forms
US20030228368A1 (en) * 2001-09-28 2003-12-11 David Wynn Edible solid composition and dosage form
CA2461870A1 (en) * 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Modified release dosage forms
US20040052844A1 (en) * 2002-09-16 2004-03-18 Fang-Hsiung Hsiao Time-controlled, sustained release, pharmaceutical composition containing water-soluble resins
US20050038042A1 (en) * 2002-11-15 2005-02-17 Jenet Codd Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders
KR101114808B1 (ko) * 2003-01-29 2012-02-15 다케다 야쿠힌 고교 가부시키가이샤 피복 제제의 제조법
EP2811982A1 (en) * 2012-02-08 2014-12-17 University Of The Witwatersrand, Johannesburg Pharmaceutical dosage form

Also Published As

Publication number Publication date
KR20130089288A (ko) 2013-08-09
EP1814529B1 (en) 2016-07-20
JP6233985B2 (ja) 2017-11-22
IL182849A0 (en) 2007-08-19
CN101076321A (zh) 2007-11-21
ZA200703810B (en) 2008-06-25
RU2458685C2 (ru) 2012-08-20
JP2008517970A (ja) 2008-05-29
CN103394087A (zh) 2013-11-20
US20090297601A1 (en) 2009-12-03
KR20070090895A (ko) 2007-09-06
MX2007005065A (es) 2007-06-25
CA2585910A1 (en) 2006-05-04
CA2585910C (en) 2013-12-17
EP1814529A1 (en) 2007-08-08
AU2005298854B2 (en) 2012-10-04
JP2013177420A (ja) 2013-09-09
AU2005298854A1 (en) 2006-05-04
WO2006045618A1 (en) 2006-05-04
JP2016183179A (ja) 2016-10-20
RU2007118585A (ru) 2008-12-10
GB0423964D0 (en) 2004-12-01
EP2298289A1 (en) 2011-03-23

Similar Documents

Publication Publication Date Title
BRPI0517391A (pt) forma de dosagem com lapso de tempo de medicamentos para a terapia de insÈnia
AR049985A1 (es) Tratamiento de combinacion para enfermedades malignas no hematologicas
AR056824A1 (es) Tableta de neramexano con matriz de liberacion modificada
DK1970059T3 (da) Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser
RU2010133489A (ru) Применение ингибиторов гамма-секретазы для лечения рака
BRPI0707235B8 (pt) formulação de fentanil sublingual sem propelente, e, dispositivo de dose unitária para administração sublingual de uma formulação de fentanil sublingual
FR15C0009I2 (fr) Compositions de gel phospholipide destinees a l'administration medicamenteuse et des methodes de traitement utilisant celles-ci
BRPI0906181A2 (pt) "método para tratamento de uma disfunção hiperproliferativa, composição farmacêutica, uso de uma combinação terapêutica na fabricação de um medicamento para o tratamento de câncer, artigo de fabricação para tratamento de uma disfunção hiperproliferativa, método para determinação de compostos a serem usados em combinação para o tratamento de câncer e método para determinação de uma combinação terapêutica a ser usada para o tratamento de câncer"
BRPI0516830A (pt) composições de droga de liberação sustentada convenientemente implantáveis
AR045972A1 (es) Formulaciones de tramadol de liberacion sostenida con eficacia de 24 horas
CY1122134T1 (el) Συνθεση για χρηση στη θεραπευτικη αντιμετωπιση της γαστρεντερικης δυσκινησιας
MXPA02012793A (es) Composicion de dilatacion rapida para la retencion gastrica y la liberacion controlada de agentes terapeuticos y formas de dosificacion de la composicion.
CY1115725T1 (el) Ενωσεις, συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη των βητα-αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων
GT200500003A (es) Composicion farmaceutica apta para la compresion directa para la administracion oral de cci-779
ATE419018T1 (de) Wärme erzeugende biokompatible keramikmaterialien
BRPI0411451A (pt) formas de dosagens orais de memantina
ATE543491T1 (de) Kombinationspräparat enthaltend ibuprofen und paracetamol
EP2392322A3 (en) Dosing regimes for trans-clomiphene
BRPI0406634A (pt) Uso de um anagrelìdeo, anagrelìdeo na forma de base, ou um sal farmaceuticamente aceitável do anagrelìdeo, composição farmacêutica não-oral, e dispositivo médido para administração transdérmica
AR046410A1 (es) Composiciones farmaceuticas para la liberacion modificada de modafinilo
DE602007012904D1 (de) Neue 2',3'-methylidenacetyladenosine prodrugs zur
EA200501223A1 (ru) Терапевтическая система, содержащая амоксициллин и клавулановую кислоту
HRP20080146T3 (en) Preoperative treatment of post operative pain
ATE541567T1 (de) Pharmazeutische zusammensetzung zur prävention und behandlung von metabolischen knochenerkrankungen mit alpha-arylmethoxyacrylat- derivaten
WO2009047779A3 (en) Composition containing fentanyl base aromatic oils and alkyl salicylate for the delivery of fentanyl base in vapour form

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2485 DE 21-08-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.